有样本,需要委托检测
带上研究问题、样本类型、数量与分组,讨论靶标检测和项目评估。
了解SIMOA服务沟通检测项目SIMOA / ASSAY
Alpha-synuclein is a presynaptic neuronal protein involved in vesicle trafficking and neurotransmitter release. In Parkinson’s disease (PD) and related synucleinopathies, misfolded and aggregated forms of alpha-synuclein accumulate in Lewy bodies, contributing to neurodegeneration and disease progre…

Alpha-synuclein is a presynaptic neuronal protein involved in vesicle trafficking and neurotransmitter release. In Parkinson’s disease (PD) and related synucleinopathies, misfolded and aggregated forms of alpha-synuclein accumulate in Lewy bodies, contributing to neurodegeneration and disease progression. Measuring total alpha-synuclein in plasma, serum, or CSF provides important insight into central nervous system pathology and may enable early detection, staging, and treatment response monitoring.
01 / DESCRIPTION
Alpha-synuclein is a presynaptic neuronal protein involved in vesicle trafficking and neurotransmitter release. In Parkinson’s disease (PD) and related synucleinopathies, misfolded and aggregated forms of alpha-synuclein accumulate in Lewy bodies, contributing to neurodegeneration and disease progression. Measuring total alpha-synuclein in plasma, serum, or CSF provides important insight into central nervous system pathology and may enable early detection, staging, and treatment response monitoring.
Due to its low abundance in blood and CSF and interference from peripheral alpha-synuclein, ultra-sensitive methods are required to measure total alpha-synuclein accurately. The Simoa® Alpha-Synuclein (Total) Advantage PLUS Assay (105737) leverages digital immunoassay technology to enable femtogram-level detection, supporting research into PD and other neurodegenerative conditions.
Quanterix’s Simoa® platform offers the precision and scalability needed to quantify biomarkers like alpha-synuclein in complex matrices with exceptional accuracy. This assay supports:
The Simoa Alpha-Synuclein (Total) Advantage PLUS Assay is a digital immunoassay intended for the quantification of total alpha-synuclein in human serum, EDTA plasma, and CSF samples, enabling research in Parkinson’s disease and other synucleinopathies. This assay is for research use only and not for diagnostic applications.
The Alpha-Synuclein (Total) Advantage PLUS Assay Kit includes all reagents and controls necessary to perform 96 tests, ensuring consistency and reliability in every run.
02 / DOCUMENTATION
保留原有原厂资料入口。不同仪器与版本的参数,请逐一核对对应文件。
NEXT STEP / 两条实验路径
带上研究问题、样本类型、数量与分组,讨论靶标检测和项目评估。
了解SIMOA服务沟通检测项目说明现有仪器、目标标记和实验条件,确认试剂、资料与适配范围。
浏览完整 Assay 目录咨询试剂与实验配置